Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Glioblastoma Multiforme

Interventions

DRUG

Verubulin

Verubulin, dose determined in Part A, i.v. once weekly, Temozolomide \& Radiation Therapy

DRUG

Temozolomide & Radiation Therapy

Temozolomide \& Radiation Therapy

Trial Locations (2)

University of Texas Health Science Center at Houston, Houston

Stanford University, Stanford